These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1804826)

  • 1. Calcium channel blockers in the management of myocardial infarction patients.
    Gheorghiade M
    Henry Ford Hosp Med J; 1991; 39(3-4):210-6. PubMed ID: 1804826
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium channel blockers in myocardial infarction.
    Skolnick AE; Frishman WH
    Arch Intern Med; 1989 Jul; 149(7):1669-77. PubMed ID: 2662933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of verapamil, nifedipine and diltiazem on experimental myocardial infarction in rats.
    Kaur AH; Singh M; Singh J; Jain K
    Indian J Exp Biol; 1985 Jan; 23(1):31-4. PubMed ID: 4018848
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative effects of three calcium antagonists (nifedipine, verapamil and diltiazem) on hemodynamics in recent myocardial infarction].
    Sakai M; Ueda K; Nakahara K; Tsuchimochi H; Mutsushita S; Kuramoto K; Murakami M
    Kokyu To Junkan; 1985 Feb; 33(2):159-64. PubMed ID: 4001593
    [No Abstract]   [Full Text] [Related]  

  • 6. [Calcium antagonists in acute myocardial infarction].
    Lotto A; Massari FM; Bertoni T; Ambrosini F; Finzi A; Foresti A; Valentini R; Matta F
    G Ital Cardiol; 1988 Nov; 18(11):974-81. PubMed ID: 3073992
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
    Moss AJ
    Circulation; 1987 Jun; 75(6 Pt 2):V148-53. PubMed ID: 3552311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers: an evidence-based review.
    Waters D
    Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blockers.
    Dipalma JR
    Am Fam Physician; 1983 Feb; 27(2):283-5. PubMed ID: 6829383
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium antagonists in secondary prevention after myocardial infarction.
    Persson S
    Drugs; 1991; 42 Suppl 2():54-60. PubMed ID: 1718702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of calcium antagonist trials in acute myocardial infarction.
    Roberts R
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic uses of calcium-blocking agents:verapamil, nifedipine, and diltiazem.
    Schwartz DJ; Wasserstrom JA; Fozzard HA
    Compr Ther; 1981 Oct; 7(10):25-33. PubMed ID: 7297044
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical review of calcium antagonists in acute myocardial infarction.
    Kendall MJ; Horton RC
    Arq Bras Cardiol; 1986 Jan; 46(1):53-8. PubMed ID: 3545157
    [No Abstract]   [Full Text] [Related]  

  • 15. The beneficial effect of nicardipine compared with nifedipine and verapamil in limiting myocardial infarct size in baboons.
    Alps BJ; Calder C; Wilson A
    Arzneimittelforschung; 1983; 33(6):868-76. PubMed ID: 6684443
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium antagonists and myocardial infarction.
    Hansen JF
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):665-70. PubMed ID: 1888690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symposium on Cardiovascular Disease and Calcium Antagonists. Introduction.
    Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):497-8. PubMed ID: 7058761
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical use of calcium channel blockers.
    Galle JS
    Conn Med; 1983 Oct; 47(10):605-10. PubMed ID: 6627936
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary note on the use of calcium antagonists in ischemic cardiopathy].
    Seu V; Abrile PG; Boero E; Magaia O; Mocini A; Castrignano A; Maffei P; Perugini P; Livi A
    Minerva Cardioangiol; 1984 Oct; 32(10):639-46. PubMed ID: 6396533
    [No Abstract]   [Full Text] [Related]  

  • 20. Why Ca2+ antagonists will be most useful before or during early myocardial ischemia and not after infarction has been established. Danish Study Group on Verapamil in Myocardial Infarction.
    Hansen JF
    Eur Heart J; 1986 Oct; 7(10):910-1. PubMed ID: 3792353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.